Commentary: Hepatocellular carcinoma: A threat for patients with Fontan circulationCentral Message
Juan Contreras, MD, David Faraoni, MD, PhD, FAHA
JTCVS Techniques · 2020
doi:10.1016/j.xjtc.2020.02.038 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Since the first Fontan operation was performed in 1968, several modifications have been introduced that led to improvement in short- and long-term survival. The current 30-year survival after Fontan completion is 85%.1,2 Hemodynamic changes associated with the Fontan circulation, including elevated central venous pressure and diminished cardiac output, as well as chronic hypoxic injury of the liver, are responsible for the development of Fontan-associated liver disease (FALD).1 In Fontan circulation, the hepatic veins discharge directly into the Fontan circuit and the liver is therefore particularly susceptible to the effects of central venous hypertension.
Abstract licence: CC BY-NC-ND
References10
10 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.